Nalaganje...
Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors: Are They All the Same? A Narrative Review of Cardiovascular Outcome Trials
Clinically important improvements in cardiovascular risk factors and adverse cardiovascular, heart failure and renal outcomes have been observed in numerous cardiovascular outcome trials (CVOTs) investigating the use of sodium-glucose co-transporter 2 (SGLT2) inhibitors over the last 5 years. Howeve...
Shranjeno v:
| izdano v: | Diabetes Ther |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Springer Healthcare
2020
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7843788/ https://ncbi.nlm.nih.gov/pubmed/33185854 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-020-00951-6 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|